ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2007;84:1796. doi:10.1016/j.athoracsur.2007.07.067
© 2007 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Egi, M.
Right arrow Articles by Bellomo, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Egi, M.
Right arrow Articles by Bellomo, R.
Related Collections
Right arrow Cardiac - pharmacology
Right arrowRelated Article

Correspondence

Reply

Moritoki Egi, MD, Rinaldo Bellomo, MD

Department of Intensive Care, Austin Hospital, 145 Studley Rd, Heidelberg, Victoria 3084, Australia

(Email: rinaldo.bellomo@austin.org.au).

The first 20% of the full text of this article appears below.

To the Editor:

We read with interest the letter by Dr Augoustides [1] and his mention of prostaglandin inhibition [2] as a potential strategy to treat vasoplegia after cardiac surgery.

We consider it . . . [Full Text of this Article]


Related Article

Management of Vasoplegia After Cardiopulmonary Bypass: Role of Prostaglandin Inhibition
John G.T. Augoustides
Ann. Thorac. Surg. 2007 84: 1796. [Extract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The Society of Thoracic Surgeons.